Stockholders' Equity (Details Textual) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended
	Feb. 28, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Granted	250,000			250,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		9,460,000		9,460,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 15,000	$ 467,600		$ 467,600
Stock Issued During Period Performance Based Options To Purchase Common Stock		6,875,000		6,875,000
Stock Options Expiration Description				options expire at various dates between 2021 and 2023
Fair Value Of Performance Based Stock Options		298,000		298,000
Unearned Share Based Compensation		298,000		298,000
Warrants Outstanding		3,637,720		3,637,720
Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercisable Weighted Average Exercise Price		$ 0.28		$ 0.28
Warrant Expiration Description				The warrants expire between 2013 and 2015
Share-based Compensation, Total		0	23,000	52,500	71,500
Fair Value Assumptions, Exercise Price		$ 0.16		$ 0.16
Fair Value Assumptions, Expected Term				5 years
Fair Value Assumptions, Expected Volatility Rate				50.00%
Fair Value Assumptions, Risk Free Interest Rate				2.00%
Fair Value Assumptions, Expected Term, Simplified Method				was amortized over three months from February 1, 2013 to April 30, 2013
Unearned compensation on unvested service-based options		7,000		7,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value				100,000
Minimum [Member]
Common Stock Exercise Price		$ 0.40		$ 0.40
Annual Sales Revenue Target				5,000,000
Maximum [Member]
Common Stock Exercise Price		$ 5.00		$ 5.00
Annual Sales Revenue Target				$ 10,000,000